Australian Clinical Labs Limited (ACL.AX) Dividend Yield, History & Forecast

Australian Clinical Labs Limited (ACL.AX) is a Medical - Diagnostics & Research company in the Healthcare sector listed on the Australian Securities Exchange. It pays a current dividend yield of 5.74% ($0.13 per share annually (TTM)). The trailing twelve-month payout ratio is 92.8%; the market capitalization is approximately $414M.

Loading quote...

Frequently Asked Questions about Australian Clinical Labs Limited (ACL.AX)

What is Australian Clinical Labs Limited's dividend yield?
Australian Clinical Labs Limited (ACL.AX) pays a current trailing twelve-month dividend yield of 5.74%, which works out to $0.13 per share annually based on the most recent payout schedule.
Is Australian Clinical Labs Limited a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Australian Clinical Labs Limited in?
Australian Clinical Labs Limited (ACL.AX) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry.
What is Australian Clinical Labs Limited's dividend payout ratio?
Australian Clinical Labs Limited (ACL.AX)'s trailing twelve-month dividend payout ratio is 92.8%. The payout ratio measures what percentage of earnings is paid out as dividends — a lower ratio generally suggests a more sustainable dividend.
Australian Clinical Labs Limited (ACL.AX) Dividend Yield, History & Forecast | Dividend Wealth